These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 14533683)

  • 1. Inhibition of Trypanosoma cruzi egress from infected fibroblasts is mediated by CD4+ and mu+ immune cells.
    Rowland EC; Chen Z
    J Parasitol; 2003 Aug; 89(4):733-7. PubMed ID: 14533683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Agglutination of Trypanosoma cruzi in infected cells treated with serum from chronically infected mice.
    Wendelken JL; Rowland EC
    J Parasitol; 2009 Apr; 95(2):337-44. PubMed ID: 18922039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [TH1 response in the experimental infection with Trypanosoma cruzi].
    Cardoni RL; Antúnez MI; Abrami AA
    Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiegressin acts late in the intracellular growth cycle of Trypanosoma cruzi to inhibit parasite egress.
    Moore-Lai D; Rowland EC
    J Parasitol; 2004 Feb; 90(1):85-91. PubMed ID: 15040671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human chagasic serum contains antibodies capable of inhibiting Trypanosoma cruzi egress from tissue culture cells.
    Costales J; Rowland EC
    J Parasitol; 2005 Aug; 91(4):950-3. PubMed ID: 17089772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation-induced T cell death exacerbates Trypanosoma cruzi replication in macrophages cocultured with CD4+ T lymphocytes from infected hosts.
    Nunes MP; Andrade RM; Lopes MF; DosReis GA
    J Immunol; 1998 Feb; 160(3):1313-9. PubMed ID: 9570549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of mice against Trypanosoma cruzi by immunization with paraflagellar rod proteins requires T cell, but not B cell, function.
    Miller MJ; Wrightsman RA; Stryker GA; Manning JE
    J Immunol; 1997 Jun; 158(11):5330-7. PubMed ID: 9164953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP; Sharma D
    Exp Parasitol; 2000 Apr; 94(4):207-16. PubMed ID: 10831388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trypanosoma cruzi: immunological consequences of parasite modification of host cells.
    Ribeiro Dos Santos R; Hudson L
    Clin Exp Immunol; 1980 Apr; 40(1):36-41. PubMed ID: 6771080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-specific Il-4- and IL-10-secreting CD4+ lymphocytes increase in vivo susceptibility to Trypanosoma cruzi infection.
    Barbosa de Oliveira LC; Curotto de Lafaille MA; Collet de Araujo Lima GM; de Almeida Abrahamsohn I
    Cell Immunol; 1996 May; 170(1):41-53. PubMed ID: 8660798
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trypanosoma cruzi: expression of antigens on the membrane surface of parasitized cells.
    Araujo FG
    J Immunol; 1985 Dec; 135(6):4149-54. PubMed ID: 3934275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Challenge of Trypanosoma cruzi chronically infected mice with trypomastigotes activates the immune system and reduces subpatent parasitemia levels.
    Marinho CR; Bastos KR; Sardinha LR; Grisotto MG; Lima MR; Alvarez JM
    J Parasitol; 2004 Jun; 90(3):516-23. PubMed ID: 15270095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discovery and characterization of an antibody, anti-egressin, that is able to inhibit Trypanosoma cruzi egress in vitro.
    Moore-Lai D; Rowland E
    J Parasitol; 2004 Jun; 90(3):524-30. PubMed ID: 15270096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immune response to Trypanosoma cruzi. An approach to the pathogenesis of Chagas' disease].
    Braun M; de Titto E
    Acta Physiol Pharmacol Latinoam; 1985; 35(1):1-47. PubMed ID: 2932884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CD4+ TH2 cell line isolated from mice chronically infected with Trypanosoma cruzi induces IgG2 polyclonal response in vivo.
    Spinella S; Milon G; Hontebeyrie-Joskowicz M
    Eur J Immunol; 1990 May; 20(5):1045-51. PubMed ID: 1972676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CTLA-4 regulates the murine immune response to Trypanosoma cruzi infection.
    Graefe SE; Jacobs T; Wächter U; Bröker BM; Fleischer B
    Parasite Immunol; 2004 Jan; 26(1):19-28. PubMed ID: 15198642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation-induced CD4+ T cell death by apoptosis in experimental Chagas' disease.
    Lopes MF; da Veiga VF; Santos AR; Fonseca ME; DosReis GA
    J Immunol; 1995 Jan; 154(2):744-52. PubMed ID: 7814881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi.
    Tarleton RL
    J Immunol; 1990 Jan; 144(2):717-24. PubMed ID: 2104903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.